Aspirin-exacerbated respiratory disease: Updates in the era of biologics

CONCLUSION: Advances in our understanding of the fundamental drivers of the chronic respiratory inflammation in asthma and CRSwNP has led to the identification of several potential therapeutic targets for these diseases that can be utilized in patients with AERD. Further study of the use of ATAD and biologic therapy, independently and together, will help to inform future treatment algorithms for patients with AERD.PMID:37225000 | DOI:10.1016/j.anai.2023.05.016
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research